2013
DOI: 10.1097/aln.0b013e318280a60a
|View full text |Cite
|
Sign up to set email alerts
|

σ1Receptors Are Involved in the Visceral Pain Induced by Intracolonic Administration of Capsaicin in Mice

Abstract: Background: Visceral pain is an important and prevalent clinical condition whose treatment is challenging. Sigma-1 (σ 1 ) receptors modulate somatic pain, but their involvement in pure visceral pain is unexplored. Methods: The authors evaluated the role of σ 1 receptors in intracolonic capsaicin-induced visceral pain (pain-related behaviors and referred mechanical hyperalgesia to the abdominal wall) using wild-type (WT) (n = 12 per group) and σ 1 receptor knockout (σ 1 -KO) (n = 10 per group) mice, selective σ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
33
0

Year Published

2014
2014
2017
2017

Publication Types

Select...
4
4

Relationship

2
6

Authors

Journals

citations
Cited by 43 publications
(38 citation statements)
references
References 50 publications
5
33
0
Order By: Relevance
“…E-52862 dose-dependently reduced mechanical allodynia and thermal hyperalgesia in a model of postoperative pain in mice [111]. E-52862 also reduced the number of behavioral responses and reversed the referred hyperalgesia in a model of capsaicin-induced visceral pain [38]. This latter result raises novel perspectives for the treatment of visceral pain.…”
Section: E-52862mentioning
confidence: 92%
See 2 more Smart Citations
“…E-52862 dose-dependently reduced mechanical allodynia and thermal hyperalgesia in a model of postoperative pain in mice [111]. E-52862 also reduced the number of behavioral responses and reversed the referred hyperalgesia in a model of capsaicin-induced visceral pain [38]. This latter result raises novel perspectives for the treatment of visceral pain.…”
Section: E-52862mentioning
confidence: 92%
“…More recently, its enhancing effect on peripheral µ-opioid analgesia has been reported when combined with other opioids including fentanyl, oxycodone, buprenorphine, loperamide and tramadol [6]. When administered systemically alone, without opioids, BD-1063 inhibited mechanical allodynia induced by capsaicin in mice [17] and was active in mice models of different types of pain, such as chemotherapy-induced neuropathic pain (paclitaxel-induced painful neuropathy) [37] and visceral pain induced by intracolonic administration of capsaicin [38]. It also reversed mechanical (paw pressure) and thermal (radiant heat) carrageenaninduced inflammatory hyperalgesia in mice when administered systemically (subcutaneously) or at the inflammation site (intraplantarly) [39].…”
Section: Bd-1047 Bd-1063 and Ne-100mentioning
confidence: 98%
See 1 more Smart Citation
“…However, this neurotoxin, and in consequence the contribution of TTX-sensitive VGSCs to visceral pain, has never been investigated in a pure visceral pain model. In the present study, we have evaluated the antinociceptive effects of TTX in three different visceral pain models in mice: the intracolonic administration of both capsaicin [24,25] and mustard oil [26,27] and a model of cyclophosphamide-induced cystitis [27,28]. These models are viscero-specific and permit the examination of both visceral pain and referred mechanical hyperalgesia to the abdominal wall, with this latter feature being clinically very relevant and characteristic of visceral pain.…”
Section: Introductionmentioning
confidence: 99%
“…refs 8, 16 and 17), they are able to decrease the pain responses induced by chemical irritants such as formalin or capsaicin (e.g. refs 18, 19, 20) as well as the sensory gain (allodynia or hyperalgesia) occurring due to sensitization of the nociceptive system by capsaicin81621 or by pathological states such as neuropathy, inflammation or ischemic pain817222324.…”
mentioning
confidence: 99%